Gil Roth06.30.11
Barry Littlejohns has been named president, Medication Delivery Solutions, at Catalent Pharma Solutions, effective July 5, 2011. Mr. Littlejohns will have full responsibility for Catalent’s Sterile Technologies and Packaging Services segments, including leading more than 2,300 employees at six facilities in both North America and Europe. He will report to John Chiminski, president and chief executive officer of Catalent, and will be based in Catalent’s Somerset, NJ global headquarters. Barry Russell, the current incumbent, will step down from that role.
Mr. Littlejohns has rejoined Catalent after two years at Danish biotechnology company Genmab, where he most recently served as senior vice president of Operations and Business Development. Prior to Genmab, Mr. Littlejohns served in a broad variety of leadership roles within Catalent during his 20-year tenure, most recently vice president of Global Business Operations, vice president and general manager of Injectables. Before that, Mr. Littlejohns served in a variety of financial, operational and leadership roles in Catalent’s drug delivery business.
Mr. Chiminski remarked, “We are very pleased to welcome Barry back to Catalent in this important role. He is a proven growth leader, with proven abilities to effectively lead teams and transform operational performance. I expect Barry will help us consolidate and extend our operational improvements in the sterile and packaging areas, and to ensure these businesses reach their full growth potential.”
Mr. Littlejohns has rejoined Catalent after two years at Danish biotechnology company Genmab, where he most recently served as senior vice president of Operations and Business Development. Prior to Genmab, Mr. Littlejohns served in a broad variety of leadership roles within Catalent during his 20-year tenure, most recently vice president of Global Business Operations, vice president and general manager of Injectables. Before that, Mr. Littlejohns served in a variety of financial, operational and leadership roles in Catalent’s drug delivery business.
Mr. Chiminski remarked, “We are very pleased to welcome Barry back to Catalent in this important role. He is a proven growth leader, with proven abilities to effectively lead teams and transform operational performance. I expect Barry will help us consolidate and extend our operational improvements in the sterile and packaging areas, and to ensure these businesses reach their full growth potential.”